SMARCB1 and neoplasm: MELTVRs and soft tissue myoepithelioma have similar histological features and changes, such as myxoid degeneration, whereas about 10% of soft tissue myoepithelioma, which is the first tumor to be identified, lack immune staining of SMARCB1 [8].